Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently with Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer.

BACKGROUND: There is a lack of data exploring the use and optimal timing of immunotherapy and chemoradiation (CRT) in node positive cervical cancer. Further translational research into mechanisms of response and resistance to immunotherapy in advanced cervical cancer is warranted. Primary Objective(...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Gynecol Cancer
Egile Nagusiak: Mayadev, Jyoti, Zamarin, Dmitriy, Deng, Wei, Lankes, Heather, O’Cearbhaill, Roisin, Aghajanian, Carol A, Schilder, Russell
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7310564/
https://ncbi.nlm.nih.gov/pubmed/31871115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2019-001012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak